The Hypotonic Environmental Changes Affect Liposomal Formulations for Nose-to-Brain Targeted Drug Delivery

被引:12
作者
Wu, Iren Yeeling [1 ]
Nikolaisen, Trygg Einar [1 ]
Skalko-Basnet, Natasa [1 ]
di Cagno, Massimiliano Pio [1 ,2 ]
机构
[1] Arctic Univ Norway, Univ Tromso, Dept Pharm, Drug Transport & Delivery Res Grp, Univ Vegen 57, N-9037 Tromso, Norway
[2] Univ Oslo, Fac Math & Nat Sci, Dept Pharm, Sem Saelands Vei 3, N-0371 Oslo, Norway
关键词
liposomes; osmotic pressure; particle size; passive diffusion; controlled release; membrane resistance; drug transport; drug delivery system; UNILAMELLAR VESICLES; MEMBRANE FLUIDITY; IN-VITRO; PERMEABILITY; STRATEGIES; MODEL; ENCAPSULATION; ABSORPTION; STABILITY; TRANSPORT;
D O I
10.1016/j.xphs.2019.03.006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Systemic administration of drugs is ineffective in the treatment of central nervous system disorders because of the blood-brain barrier. Nasal administration has been suggested as an alternative administration route as drugs absorbed in the olfactory epithelium bypass the blood-brain barrier and reach the brain within minutes. However, the nasal mucosa properties (e.g., tonicity, pH) are not constant because of physiological and environmental factors, and this might limit the therapeutic outcome of nanocarrier-based formulations. To shine light on the impact of environmental ionic strength on nanocarrier-based formulations, we have studied how liposomal formulations respond to the change of tonicity of the external environment. Large unilamellar vesicles loaded with 6 different drugs were exposed to different hypotonic environments, creating an osmotic gradient within the inner core and external environment of the liposomes up to 650 mOsm/kg. Both size and polydispersity of liposomes were significantly affected by tonicity changes. Moreover, the release kinetics of hydrophilic and lipophilic drugs were largely enhanced by hypotonic environments. These results clearly demonstrate that the environmental ionic strength has an impact on liposomal formulation stability and drug release kinetics and it should be considered when liposomal formulations for nose-to-brain targeted drug delivery are designed. (C) 2019 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:2570 / 2579
页数:10
相关论文
共 55 条
[1]   Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease [J].
Agrawal, Mukta ;
Ajazuddin ;
Tripathi, Dulal K. ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Antimisiaris, Sophia G. ;
Mourtas, Spyridon ;
Hammarlund-Udenaes, Margareta ;
Alexander, Amit .
JOURNAL OF CONTROLLED RELEASE, 2017, 260 :61-77
[2]   Response of unilamellar DPPC and DPPC:SM vesicles to hypo and hyper osmotic shocks: A comparison [J].
Ahumada, M. ;
Calderon, C. ;
Alvarez, C. ;
Lanio, M. E. ;
Lissi, E. A. .
CHEMISTRY AND PHYSICS OF LIPIDS, 2015, 188 :54-60
[3]   Strategy for effective brain drug delivery [J].
Alam, M. Intakhab ;
Beg, Sarwar ;
Samad, Abdus ;
Baboota, Sanjula ;
Kohli, Kanchan ;
Ali, Javed ;
Ahuja, Alka ;
Akbar, M. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 40 (05) :385-403
[4]  
[Anonymous], 1990, LIPOSOMES PRACTICAL, P1
[5]  
BANGHAM A.D., 1967, CHEM PHYS LIPIDS, VI, P225, DOI [10.1016/0009-3084(67)90030-8, DOI 10.1016/0009-3084(67)90030-8]
[6]   NEGATIVE STAINING OF PHOSPHOLIPIDS + THEIR STRUCTURAL MODIFICATION BY-SURFACE ACTIVE AGENTS AS OBSERVED IN ELECTRON MICROSCOPE [J].
BANGHAM, AD ;
HORNE, RW .
JOURNAL OF MOLECULAR BIOLOGY, 1964, 8 (05) :660-&
[7]   Salt-induced aggregation in cationic liposome aqueous suspensions resulting in multi-step self-assembling complexes [J].
Bordi, F ;
Cametti, C .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2002, 26 (04) :341-350
[8]   INCREASE IN MEMBRANE FLUIDITY IN LIPOSOMES AND PLANT PROTOPLASTS UPON OSMOTIC SWELLING [J].
BOROCHOV, A ;
BOROCHOV, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 550 (03) :546-549
[9]   Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics [J].
Bourganis, Vassilis ;
Kammona, Olga ;
Alexopoulos, Aleck ;
Kiparissides, Costas .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 128 :337-362
[10]  
Brodin B, 2010, MOL BIOPHARMACEUTICS, P135